In conclusion, this study confirms that, aside from female breast and ovarian cancers, BRCA1/2 PVs are associated with increased risks of breast cancer in men, and pancreatic and stomach cancers in both sexes, and that only BRCA2 carriers are at elevated prostate cancer risk. This evidence concerns the gene BRCA2 and gastric cancer.